September 10, 2007
BL Licenses Kirin's Tech. to Develop Antibody Pharmaceuticals Kirin Pharma and Immuno-Biological Laboratories (IBL; http://www.ibl-japan.co.jp ) announced on August 30 the conclusion of a license agreement on Kirin's technology related to mice producing complete human antibodies. Under this agreement, IBL...read more